In a survey of pediatric patients with vitiligo, only 51.4% were offered narrowband ultraviolet B (NB-UVB) phototherapy, and 45.1% received this treatment before the age of 18 years. The main barriers ...

In a phase 2 study, adding narrow-band UVB phototherapy (NB-UVB) resulted in meaningful repigmentation through week 48 without new safety concerns in patients with nonsegmental vitiligo who did not ...

New Orleans, LA – A randomized, placebo-controlled pilot study led by Frank Lau, MD, FACS, Associate Professor of Clinical Surgery at LSU Health New Orleans School of Medicine, has found that ...

Think about a world where a light is restoring your skin’s lost color. Red light therapy lamp is becoming popular for skin pigmentation treatment among people with vitiligo. The common skin condition, ...

Please provide your email address to receive an email when new articles are posted on . At week 24, the ritlecitinib plus nbUVB group saw a higher facial vitiligo severity change from baseline vs. the ...

Credit: Getty Images The Vitiligo Task Force developed expert-based recommendations for the treatment of vitiligo, worldwide. The International Vitiligo Task Force has issued up-to-date evidence-based ...

A retrospective study investigated skin cancer risk in a large cohort of patients treated with ultraviolet light therapy between May 1977 and November 2018. Patients were treated with narrowband UVB ...

SCENESSE® is being evaluated as a systemic repigmentation therapy for vitiligo patients, with a clinical focus on adolescent (12 years and above) and adult patients with darker skin types (Fitzpatrick ...

HORSHAM, Pa., March 20, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and ...

Patients with vitiligo can increase repigmentation through vitamin D and topical corticosteroid therapy. Combining topical corticosteroids with vitamin D analogues resulted in greater efficacy rates ...